BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29772538)

  • 1. Targeting fibroblast activation protein in cancer - Prospects and caveats.
    Busek P; Mateu R; Zubal M; Kotackova L; Sedo A
    Front Biosci (Landmark Ed); 2018 Jun; 23(10):1933-1968. PubMed ID: 29772538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy.
    Hamson EJ; Keane FM; Tholen S; Schilling O; Gorrell MD
    Proteomics Clin Appl; 2014 Jun; 8(5-6):454-63. PubMed ID: 24470260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast activation protein in liver fibrosis.
    Lay AJ; Zhang HE; McCaughan GW; Gorrell MD
    Front Biosci (Landmark Ed); 2019 Jan; 24(1):1-17. PubMed ID: 30468644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
    Juillerat-Jeanneret L; Tafelmeyer P; Golshayan D
    Expert Opin Ther Targets; 2017 Oct; 21(10):977-991. PubMed ID: 28829211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications.
    Šimková A; Bušek P; Šedo A; Konvalinka J
    Biochim Biophys Acta Proteins Proteom; 2020 Jul; 1868(7):140409. PubMed ID: 32171757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast activation protein: A potential therapeutic target in cancer.
    Liu R; Li H; Liu L; Yu J; Ren X
    Cancer Biol Ther; 2012 Feb; 13(3):123-9. PubMed ID: 22236832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.].
    Pleshkan VV; Alekseenko IV; Tyulkina DV; Kyzmich AI; Zinovyeva MV; Sverdlov ED
    Mol Gen Mikrobiol Virusol; 2016; 34(3):90-97. PubMed ID: 30383930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment.
    Zhang Z; Tao J; Qiu J; Cao Z; Huang H; Xiao J; Zhang T
    Cell Oncol (Dordr); 2024 Apr; 47(2):361-381. PubMed ID: 37726505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of the fibroblast activation protein α-targeted immunotherapy strategy.
    Jiang GM; Xu W; Du J; Zhang KS; Zhang QG; Wang XW; Liu ZG; Liu SQ; Xie WY; Liu HF; Liu JS; Wu BP
    Oncotarget; 2016 May; 7(22):33472-82. PubMed ID: 26985769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens.
    Zhang J; Valianou M; Simmons H; Robinson MK; Lee HO; Mullins SR; Marasco WA; Adams GP; Weiner LM; Cheng JD
    FASEB J; 2013 Feb; 27(2):581-9. PubMed ID: 23104982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.
    Brennen WN; Rosen DM; Wang H; Isaacs JT; Denmeade SR
    J Natl Cancer Inst; 2012 Sep; 104(17):1320-34. PubMed ID: 22911669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
    LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR
    Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy.
    Brennen WN; Isaacs JT; Denmeade SR
    Mol Cancer Ther; 2012 Feb; 11(2):257-66. PubMed ID: 22323494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).
    Zi F; He J; He D; Li Y; Yang L; Cai Z
    Mol Med Rep; 2015 May; 11(5):3203-11. PubMed ID: 25593080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
    Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
    Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
    Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
    Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short hairpin RNA targeting of fibroblast activation protein inhibits tumor growth and improves the tumor microenvironment in a mouse model.
    Cai F; Li Z; Wang C; Xian S; Xu G; Peng F; Wei Y; Lu Y
    BMB Rep; 2013 May; 46(5):252-7. PubMed ID: 23710635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.
    Lai D; Ma L; Wang F
    Int J Oncol; 2012 Aug; 41(2):541-50. PubMed ID: 22614695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
    Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
    Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics.
    Zhang HE; Hamson EJ; Koczorowska MM; Tholen S; Chowdhury S; Bailey CG; Lay AJ; Twigg SM; Lee Q; Roediger B; Biniossek ML; O'Rourke MB; McCaughan GW; Keane FM; Schilling O; Gorrell MD
    Mol Cell Proteomics; 2019 Jan; 18(1):65-85. PubMed ID: 30257879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.